Van HoutAMde WitNJRuttenFHPeetersPH. Determinants of patient’s and doctor’s delay in diagnosis and treatment of colorectal cancer. Eur J Gastroenterol Hepatol. 2011;23:1056-1063.
2.
MenjakIBGuptaAGrinmanMN. Delayed diagnosis of metastatic Ewing sarcoma masked by Charcot-Marie-Tooth disease. J Adolesc Young Adult Oncol. 2013;2:175-178.
3.
MacleodUMitchellEDBurgessCMacdonaldSRamirezAJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009;101(suppl 2):S92-S101.
ChangETAdamiHO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765-1777.
6.
LeongJLFongKWLowWK. Factors contributing to delayed diagnosis in nasopharyngeal carcinoma. J Laryngol Otol. 1999;113:633-636.
7.
LeeAWSzeWMAuJS. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107-1116.
8.
LiuMTHsiehCYChangTHLinJPHuangCCWangAY. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 2003;33:501-508.
9.
BrayFHaugenMMogerTATretliSAalenOOGrotmolT. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev. 2008;17:2356-2365.
10.
LiXFasanoRWangEYaoKTMarincolaF. HLA associations with nasopharyngeal carcinoma. Curr Mol Med. 2009;9:751-765.
